Organization
Beverly Hills Cancer Care
3 abstracts
Abstract
Trilaciclib combined with sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC): Updated phase 2 safety and efficacy results.Org: Los Angeles Cancer Network, Inova Schar Cancer Institute, Northwest Medical Specialties, Virginia Oncology Associates, Valkyrie Clinical Trials, Inc,
Abstract
A FINANCIAL IMPACT ASSESSMENT OF INTRODUCING LUMIRACOXIB ONTO THE FORMULARY OF THE UK NATIONAL HEALTH SERVICE FOR THE MANAGEMENT OF PATIENTS WITH OSTEOARTHRITISOrg: Health Economics and Health Services Research, Cerner LifeSciences, Beverly Hills Cancer Care, Novartis Pharmaceuticals Corporation, East Hanover, NJ,
Abstract
A COST-EFFICACY COMPARISON OF BIOLOGIC AGENTS IN THE TREATMENT OF RHEUMATOID ARTHRITISOrg: Health Economics and Health Services Research, Zynx Health-Cerner Corporation, Beverly Hills Cancer Care, Pharmacoeconomics and Outcomes Research Iberia (PORIB), Madrid, Spain, Amgen,